Location History:
- Lyon, FR (1976 - 1979)
- Lyons, FR (1979)
Company Filing History:
Years Active: 1976-1979
Title: Marie-France Makula: A Pioneer in Purified Albumin Research
Introduction
Marie-France Makula, a distinguished inventor based in Lyon, France, has made significant strides in the field of biotechnology with her groundbreaking research. With a total of three patents to her name, she has contributed to innovative processes that enhance the preparation and application of purified albumin. Her work has implications not only for scientific research but also for medical applications.
Latest Patents
Makula's latest patents include a novel process for the preparation of purified albumin. This innovative method involves using frozen placenta, placental blood, or other hemolyzed blood as starting materials. The process carefully eliminates hemoglobin, enzymes, and group substances to yield a highly purified protein product. Additionally, she has developed a method for producing a gamma globulin-rich fraction from conventional ethanol fractionation of whole placenta, showcasing her expertise in extracting valuable components from biological materials.
Career Highlights
Marie-France Makula is affiliated with the Institut Merieux, a leader in microbiological testing and biotechnology. Her career is marked by her commitment to advancing medical research and her efforts to make safe and effective protein products widely available. This dedication has positioned her as a prominent figure in the scientific community, contributing to the enhancement of medical treatments.
Collaborations
Throughout her career, Makula has collaborated with esteemed colleagues such as Robert A Plan and Jacques C Liautaud, further enriching her research through shared knowledge and expertise. These partnerships have enabled her to expand the scope of her inventions and drive innovation in her field.
Conclusion
Marie-France Makula's contributions to the field of purified albumin research are invaluable. Her patents not only showcase her creativity and scientific acumen but also have the potential to improve medical treatments significantly. As she continues her work at the Institut Merieux, her future innovations are eagerly anticipated by the scientific and medical communities alike.